Skip to Content

Maravai LifeSciences Holdings Inc Ordinary Shares - Class A MRVI

Morningstar Rating
$7.07 −0.17 (2.35%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

MRVI is trading at a 372% premium.
Price
$7.11
Fair Value
$97.58
Uncertainty
Very High
1-Star Price
$41.99
5-Star Price
$1.59
Economic Moat
Jff
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if MRVI is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$7.24
Day Range
$6.997.34
52-Week Range
$4.5213.31
Bid/Ask
$6.66 / $7.41
Market Cap
$939.11 Mil
Volume/Avg
1.4 Mil / 2.0 Mil

Key Statistics

Price/Earnings (Normalized)
125.45
Price/Sales
3.41
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Maravai LifeSciences Holdings Inc is a life sciences company. It provides products to enable the development of drug therapies, diagnostics, and novel vaccines and supports research on human diseases. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.
Sector
Healthcare
Industry
Biotechnology
Stock Style Box
Small Growth
Total Number of Employees
570

Comparables

Valuation

Metric
MRVI
TIHE
RXDX
Price/Earnings (Normalized)
125.45
Price/Book Value
2.2913.67
Price/Sales
3.412,138.36
Price/Cash Flow
67.61
Price/Earnings
MRVI
TIHE
RXDX

Financial Strength

Metric
MRVI
TIHE
RXDX
Quick Ratio
10.1936.90
Current Ratio
11.3237.56
Interest Coverage
13.71
Quick Ratio
MRVI
TIHE
RXDX

Profitability

Metric
MRVI
TIHE
RXDX
Return on Assets (Normalized)
−0.31%−27.00%
Return on Equity (Normalized)
−1.28%−30.83%
Return on Invested Capital (Normalized)
0.45%−31.90%
Return on Assets
MRVI
TIHE
RXDX
See how this stock stacks up to its competitors with Morningstar Investor

Biotechnology Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Novo Nordisk A/S ADR
NVO
ZfsdfftylFpv$631.5 Bil
Vertex Pharmaceuticals Inc
VRTX
JqrdfryvHmnnjr$122.6 Bil
Regeneron Pharmaceuticals Inc
REGN
SzqrpsjcWbjhtxd$117.3 Bil
Moderna Inc
MRNA
WcdzbryrLdnw$52.5 Bil
Alnylam Pharmaceuticals Inc
ALNY
JpvxkcbFbwlxr$28.2 Bil
argenx SE ADR
ARGX
DwfkvzqgsMybpn$23.7 Bil
BioNTech SE ADR
BNTX
XjcdbdttVrd$20.9 Bil
Biomarin Pharmaceutical Inc
BMRN
HdqcwsmnxKhtmhc$16.2 Bil
United Therapeutics Corp
UTHR
JwhbnkfzgTbfc$14.1 Bil
Incyte Corp
INCY
ZcrjddwfDgtxjq$12.6 Bil

Sponsor Center